Education
About Us
Working with TipRanks
Follow Us
Lakeshore Biopharma Co., Ltd (LSBCF)
:LSBCF
LSBCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.30 - $8.60
Previous CloseN/A
VolumeN/A
Average Volume (3M)79.61K
Market Cap
$30.50M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Jan 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding41,212,692
10 Day Avg. Volume170,152
30 Day Avg. Volume79,607
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LSBCF FAQ
What was Lakeshore Biopharma Co., Ltd’s price range in the past 12 months?
Lakeshore Biopharma Co., Ltd lowest stock price was $0.30 and its highest was $8.60 in the past 12 months.
What is Lakeshore Biopharma Co., Ltd’s market cap?
Lakeshore Biopharma Co., Ltd’s market cap is $30.50M.
When is Lakeshore Biopharma Co., Ltd’s upcoming earnings report date?
Lakeshore Biopharma Co., Ltd’s upcoming earnings report date is Jan 26, 2026 which is in 115 days.
How were Lakeshore Biopharma Co., Ltd’s earnings last quarter?
Currently, no data Available
Is Lakeshore Biopharma Co., Ltd overvalued?
According to Wall Street analysts Lakeshore Biopharma Co., Ltd’s price is currently Overvalued.
Does Lakeshore Biopharma Co., Ltd pay dividends?
Lakeshore Biopharma Co., Ltd does not currently pay dividends.
What is Lakeshore Biopharma Co., Ltd’s EPS estimate?
Lakeshore Biopharma Co., Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lakeshore Biopharma Co., Ltd have?
Lakeshore Biopharma Co., Ltd has 41,212,692 shares outstanding.
What happened to Lakeshore Biopharma Co., Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lakeshore Biopharma Co., Ltd?
Currently, no hedge funds are holding shares in LSBCF
LakeShore Biopharma Stock Smart Score
Company Description
Lakeshore Biopharma Co., Ltd
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
Technical Analysis
CASI Pharmaceuticals
―
Atara Biotherapeutics
―
NRX Pharmaceuticals
―
Werewolf Therapeutics
―
Radiopharm Theranostics Limited Sponsored ADR
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.39% Other Institutional Investors
99.61% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---